Changxia Shao

10PUBLICATIONS
18CO-AUTHORS
Cancer geneticsOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 26, 2025
Prevalence of Homologous Recombination Repair Mutations and Association with Clinical Outcomes in Patients with Solid Tumors: A Study Using the AACR Project GENIE Dataset.

Changxia Shao, Heng Zhou, Cai Chen

|Nov 06, 2024
Incidence of Undifferentiated Pleomorphic Sarcoma (UPS) in the United States.

Jiemin Ma, Roman Groisberg, Changxia Shao

|Jun 12, 2024
Prevalence and prognosis of hypoxia-inducible factor-2α (HIF-2α) pathway gene mutations across advanced solid tumors.

Wenjun Zhong, Jiemin Ma, Cai Chen

|Jun 10, 2024
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.

Min-Hyun Baek, Lei Chen, Cumhur Tekin

|Jan 03, 2024
Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.

Changxia Shao, Yixin Ren, Heng Zhou

|Nov 16, 2023
Association Between Homologous Recombination Repair Biomarkers and Survival in Patients With Solid Tumors.

Changxia Shao, Yixin Ren, Heng Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Sumesh Kachroo

2 joint publications

Yixin Ren

2 joint publications

Elisha J Dettman

2 joint publications

Wenjun Zhong